Lucas Adams (MSTP in PhD training)

  • McAlester, OK

  • Oklahoma Baptist University (2016)

  • Immunology

  • Daved H. Fremont, Ph.D.

  • Structural basis of SARS-CoV-2 immune surveillance/evasion



With Daved Fremont and Michael Diamond, I use structural and biophysical techniques to study host-virus interactions, including immune surveillance and evasion. My current focus is SARS-CoV-2, the causative agent of the COVID-19 pandemic. Current clinical interventions for COVID-19 include vaccines and monoclonal antibodies (mAbs) designed to combat ancestral strains of the virus, but emerging SARS-CoV-2 variants have developed resistance. I study how the immune system recognizes and combats these variants of concern/interest (VOC/VOI), including detailed structural studies of antibodies. Our work may lead to the development of new interventions (e.g. broadly protective mAbs) or guide the improvement of existing tools.

Graduate Publications:

VanBlargan LA*, Adams LJ*, Liu Z*, Chen RE, Gilchuk P, Raju S, Smith BK, Zhao H, Case JB, Winkler ES, Whitener BM, Droit L, Aziati ID, Bricker TL, Joshi A, Shi PY, Creanga A, Pegu A, Handley SA, Wang D, Boon ACM, Crowe JE Jr, Whelan SPJ, Fremont DH, Diamond MS. 2021 A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope.. Immunity, ():S1074-7613(21)00348-4.

Smith BK, Janowski AB, Fremont AC, Adams LJ, Dai YN, Farnsworth CW, Gronowski AM, Roper SM, Wang D, Fremont DH. 2021 Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021. mSphere, 6(4):e0045021.

Hassan AO, Shrihari S, Gorman MJ, Ying B, Yaun D, Raju S, Chen RE, Dmitriev IP, Kashentseva E, Adams LJ, Mann C, Davis-Gardner ME, Suthar MS, Shi PY, Saphire EO, Fremont DH, Curiel DT, Alter G, Diamond MS. 2021 An intranasal vaccine durably protects against SARS-CoV-2 variants in mice. Cell Rep, 36(4):109452.

Bricker TL, Darling TL, Hassan AO, Harastani HH, Soung A, Jiang X, Dai YN, Zhao H, Adams LJ, Holtzman MJ, Bailey AL, Case JB, Fremont DH, Klein R, Diamond MS, Boon ACM. 2021 A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters. Cell Rep, 36(3):109400.

Case JB, Rothlauf PW, Chen RE, Kafai NM, Fox JM, Smith BK, Shrihari S, McCune BT, Harvey IB, Keeler SP, Bloyet LM, Zhao H, Ma M, Adams LJ, Winkler ES, Holtzman MJ, Fremont DH, Whelan SPJ, Diamond MS. 2020 Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice. Cell Host Microbe, 28(3):465-474.e4.

Hassan AO, Kafai NM, Dmitriev IP, Fox JM, Smith BK, Harvey IB, Chen RE, Winkler ES, Wessel AW, Case JB, Kashentseva E, McCune BT, Bailey AL, Zhao H, VanBlargan LA, Dai YN, Ma M, Adams LJ, Shrihari S, Danis JE, Gralinski LE, Hou YJ, Schäfer A, Kim AS, Keeler SP, Weiskopf D, Baric RS, Holtzman MJ, Fremont DH, Curiel DT, Diamond MS. 2020 A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2. Cell, 183(1):169-184.e13.

Zhang R, Earnest JT, Kim AS, Winkler ES, Desai P, Adams LJ, Hu G, Bullock C, Gold B, Cherry S, Diamond MS. 2019 Expression of the Mxra8 Receptor Promotes Alphavirus Infection and Pathogenesis in Mice and Drosophila. Cell Rep, 28(10):2647-2658.e5.

Last Updated: 9/14/2021 7:03:06 PM

Back To Top

Follow us: